Literature DB >> 27605596

Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark.

Mette Pinholt1,2, Heidi Gumpert3, Sion Bayliss4, Jesper B Nielsen3, Veronika Vorobieva5, Michael Pedersen6, Edward Feil4, Peder Worning3, Henrik Westh3,2.   

Abstract

OBJECTIVES: From 2012 to 2014, there has been a huge increase in vancomycin-resistant (vanA) Enterococcus faecium (VREfm) in Copenhagen, Denmark, with 602 patients infected or colonized with VREfm in 2014 compared with just 22 in 2012. The objective of this study was to describe the genetic epidemiology of VREfm to assess the contribution of clonal spread and horizontal transfer of the vanA transposon (Tn1546) and plasmid in the dissemination of VREfm in hospitals.
METHODS: VREfm from Copenhagen, Denmark (2012-14) were whole-genome sequenced. The clonal structure was determined and the structure of Tn1546-like transposons was characterized. One VREfm isolate belonging to the largest clonal group was sequenced using long-read technology to close a 37 kb vanA plasmid.
RESULTS: Phylogeny revealed a polyclonal structure where 495 VREfm isolates were divided into 13 main groups and 7 small groups. The majority of the isolates were located in three groups (n = 44, 100 and 218) and clonal spread of VREfm between wards and hospitals was identified. Five Tn1546-like transposon types were identified. A dominant truncated transposon (type 4, 92%) was spread across all but one VREfm group. The closed vanA plasmid was highly covered by reads from isolates containing the type 4 transposon.
CONCLUSIONS: This study suggests that it was the dissemination of the type 4 Tn1546-like transposon and plasmid via horizontal transfer to multiple populations of E. faecium, followed by clonal spread of new VREfm clones, that contributed to the increase in and diversity of VREfm in Danish hospitals.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27605596     DOI: 10.1093/jac/dkw360

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Expansion of Vancomycin-Resistant Enterococcus faecium in an Academic Tertiary Hospital in Southwest Germany: a Large-Scale Whole-Genome-Based Outbreak Investigation.

Authors:  Jan Liese; Leonard Schüle; Philipp Oberhettinger; Leonie Tschörner; Tran Nguyen; Daniela Dörfel; Wichard Vogel; Matthias Marschal; Ingo Autenrieth; Matthias Willmann; Silke Peter
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 2.  Whole-Genome Sequencing of Bacterial Pathogens: the Future of Nosocomial Outbreak Analysis.

Authors:  Scott Quainoo; Jordy P M Coolen; Sacha A F T van Hijum; Martijn A Huynen; Willem J G Melchers; Willem van Schaik; Heiman F L Wertheim
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

3.  Within-host evolution of Enterococcus faecium during longitudinal carriage and transition to bloodstream infection in immunocompromised patients.

Authors:  Danesh Moradigaravand; Theodore Gouliouris; Beth Blane; Plamena Naydenova; Catherine Ludden; Charles Crawley; Nicholas M Brown; M Estée Török; Julian Parkhill; Sharon J Peacock
Journal:  Genome Med       Date:  2017-12-27       Impact factor: 11.117

4.  Hospital acquired vancomycin resistant enterococci in surgical intensive care patients - a prospective longitudinal study.

Authors:  Stefanie Kampmeier; Annelene Kossow; Larissa Monika Clausen; Dennis Knaack; Christian Ertmer; Antje Gottschalk; Hendrik Freise; Alexander Mellmann
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-23       Impact factor: 4.887

5.  Phenotypic and Genotypic Traits of Vancomycin-Resistant Enterococci from Healthy Food-Producing Animals.

Authors:  Valerie Wist; Marina Morach; Marianne Schneeberger; Nicole Cernela; Marc J A Stevens; Katrin Zurfluh; Roger Stephan; Magdalena Nüesch-Inderbinen
Journal:  Microorganisms       Date:  2020-02-15

6.  In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient.

Authors:  Eric Wenzler; Maressa Santarossa; Kevin A Meyer; Amanda T Harrington; Gail E Reid; Nina M Clark; Fritzie S Albarillo; Zackery P Bulman
Journal:  Open Forum Infect Dis       Date:  2020-01-04       Impact factor: 3.835

Review 7.  Antimicrobial-Resistant Evolution and Global Spread of Enterococcus faecium Clonal Complex (CC) 17: Progressive Change from Gut Colonization to Hospital-Adapted Pathogen.

Authors:  Zixin Peng; Lin Yan; Shuran Yang; Dajin Yang
Journal:  China CDC Wkly       Date:  2022-01-14

8.  The Role of Whole Genome Sequencing in the Surveillance of Antimicrobial Resistant Enterococcus spp.: A Scoping Review.

Authors:  Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley
Journal:  Front Public Health       Date:  2021-06-10

9.  Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.

Authors:  Yoshihiro Fujiya; Tetsuya Harada; Yo Sugawara; Yukihiro Akeda; Masako Yasuda; Ayako Masumi; Junichi Hayashi; Nobuhiro Tanimura; Yoshihiro Tsujimoto; Wataru Shibata; Takahiro Yamaguchi; Ryuji Kawahara; Isao Nishi; Shigeyuki Hamada; Kazunori Tomono; Hiroshi Kakeya
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

10.  Epidemiological and genetic characteristics of vancomycin-resistant Enterococcus faecium isolates in a University Children's Hospital in Germany: 2019 to 2020.

Authors:  Ilona Trautmannsberger; Laura Kolberg; Melanie Meyer-Buehn; Johannes Huebner; Guido Werner; Robert Weber; Valerie Heselich; Sebastian Schroepf; Hans-Georg Muench; Ulrich von Both
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-12       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.